Mostafa L. Salam-Abdel
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
Publisher Correction: Interactomic exploration of LRRC8A in volume-regulated anion channels.
Journal: Cell death discovery
Published: August 29, 2024
Interactomic exploration of LRRC8A in volume-regulated anion channels.
Journal: Cell death discovery
Published: November 27, 2023
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 25, 2022
Acute toxicity and antitumor potential of 1,3,4-trisubstituted-1,2,3-triazole dhmtAc-loaded liposomes on a triple-negative breast cancer model.
Journal: Archiv der Pharmazie
Published: January 11, 2022
LyeTx I-b Peptide Attenuates Tumor Burden and Metastasis in a Mouse 4T1 Breast Cancer Model.
Journal: Antibiotics (Basel, Switzerland)
Published: August 06, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026